- 询价
- Nebulabio
- 中国
- NBL-288274
- 2025年12月23日
企业认证
相关产品推荐更多 >
![Zoxamide, KLH [Antigen]](https://img1.dxycdn.com/p/s14/2025/0919/905/8275649941890498691.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug; 500ug; 1mg; Bulk
| 产品信息
品名：NebuSelect™ Recombinant Canine IL-8/CXCL8
中文名称：重组Canine IL-8/CXCL8蛋白
别名：P41324, IL-8/CXCL8, IL8.
货号：NBL-288274
品牌：Nebulabio
规格：100UG；1MG；Bulk
| 产品描述
NebuSelect™ Recombinant Canine IL-8/CXCL8 (CAT#NBL-288274) is expressed in E.coli. This recombinant protein is of high purity, verified to be greater than 95% by SDS-PAGE. Endotoxin levels are less than 1 EU/µg, as determined by the LAL (Limulus Amebocyte Lysate) assay. Please contact us freely to get bioactivity data.
| 产品属性
Species:Canine
Expression System:E.coli
Molecular Weight:9.1 kDa
Target Name:IL-8/CXCL8
Purity:＞95%
Formulation:See COA
Endotoxin:＜1 EU/ug(LAL Method)
Storage:4°C for short term. -20°C for long term.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Canine Adenovirus Downstream Processing Protocol
against the vectors. This preexisting immunity limits their clinical success. Strategies to circumvent this problem include the use of nonhuman adenovirus vectors. Vectors derived from canine adenovirus type 2 (CAV-2) are among the best-studied representatives. CAV
Gene Transfer to Brain and Spinal Cord Using Recombinant Adenoviral Vectors
Recombinant adenoviral (Ad) vectors are derived from human adenoviruses: nonenveloped, encapsidated linear, double-stranded DNA viruses that commonly cause respiratory and gastrointestinal infections. Forty-three different human adenovirus
) and zinc finger (Zn) domains, and splice sites. The cap ORF produces three proteins, and the starts sites (VP1, VP2, and VP3) are indicted by right-angled arrows. Regions proposed to be on the exterior of the AAV2 capsid based on homology with canine
技术资料暂无技术资料 索取技术资料
